Abstract

The B7 family consists of activating and inhibitory co-stimulatory molecules that positively and negatively regulate immune responses. Recent studies have shown that human and rodent cancer cells, and stromal cells and immune cells in the cancer microenvironment upregulate expression of inhibitory B7 molecules and that these contribute to tumour immune evasion. In this Review, we focus on the roles of these B7 molecules in the dynamic interactions between tumours and the host immune system, including their expression, regulation and function in the tumour microenvironment. We also discuss novel therapeutic strategies that target these inhibitory B7 molecules and their signalling pathways to treat human cancer.

Author affiliations

1. Department of Surgery, University of Michigan, Ann Arbor, Michigan 48109, USA.
   Email: wzou@med.umich.edu
2. Departments of Dermatology and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA.
   Email: lchen42@jhmi.edu

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.